Potential Benefits of Parent Child Interaction Therapy (PCIT)
Launched by UNIVERSITY OF FLORIDA · Feb 13, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the benefits of Parent-Child Interaction Therapy (PCIT) for families dealing with issues like anxiety, depression, and difficulties in parent-child relationships. The main goal is to see how this therapy can improve family dynamics and individual well-being. Researchers want to understand how certain factors, like a child's physical response to stress, relate to how well families are functioning. To participate, parents must have children aged 2 to 7 who are facing behavioral challenges and be willing to complete several online surveys before, during, and after the therapy sessions.
Eligible participants include primary caregivers who are actively involved in their child's daily care and can attend all therapy sessions. It's important that participants are fluent in English to fully understand the program. However, parents with severe mental health issues or children with specific developmental needs that require different treatments cannot join the study. Overall, this trial aims to help families improve their relationships and manage challenges more effectively through the PCIT program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parents of children aged 2-7 years old who are eligible for Parent-Child Interaction Therapy (PCIT) based on behavioral concerns.
- • The primary caregiver of the child and be actively involved in the child's daily care.
- • Willing to attend all PCIT sessions and complete pre-, mid- and post-intervention assessments.
- • Fluent in English to ensure comprehension of the intervention and assessment materials.
- Exclusion Criteria:
- • Parents with diagnosed severe mental health disorders (e.g., schizophrenia, bipolar disorder) that may interfere with participation in PCIT.
- • Children with conditions that require interventions other than PCIT (e.g., severe developmental disabilities).
- • Parents who have previously participated in PCIT are excluded to avoid confounding results.
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Jacksonville, Florida, United States
Patients applied
Trial Officials
Britney N. Duner, LCSW
Principal Investigator
University of Florida College of Medicine Jacksonville
Liliana L. Acosta, PhD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported